I love these... it's like critizing Dwight Gooden in his rookie year for having no playoff wins. My only hope is that a computer generated this. If there's a human behind it, the ignorance is scary.
NEW YORK (TheStreet) -- Pharmacyclics Incorporated (Nasdaq:PCYC) has been downgraded by TheStreet Ratings from buy to hold. The company's strengths can be seen in multiple areas, such as its largely solid financial position with reasonable debt levels by most measures, notable return on equity and expanding profit margins. However, as a counter to these strengths, we also find weaknesses including unimpressive growth in net income, weak operating cash flow and feeble growth in the company's earnings per share